不同剂量氟伐他汀对冠状动脉斑块性质、高敏C反应蛋白及血脂水平的影响

    Influence of different dose fluvastatin on the coronary artery plaque, and levels of serum lipids and high sensitive C-reactive protein

    • 摘要: 目的:观察氟伐他汀每晚40 mg及每晚80mg治疗冠心病患者冠状动脉内斑块性质、血清高敏C反应蛋白(hs-CRP)和血脂水平的影响及安全性。方法:冠心病患者120例随机分为氟伐他汀每晚80 mg(A组)、40 mg(B组)和对照组(C组)各40例,共6个月的治疗,治疗前后均进行冠状动脉CT造影检查。比较冠状动脉内斑块性质、血清中hs-CRP、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和肝功能的变化。结果:3组患者治疗前血清hs-CRP水平、TC、TG、LDL-C、HDL-C水平差异均无统计学意义(P>0.05)。治疗6个月后A组和B组血清hs-CRP、TC、TG、LDL-C水平均较治疗前降低,HDL-C水平均较治疗前升高(P<0.01),A组治疗后LDL-C水平低于B组(P<0.01)。A、B组治疗6个月后冠状动脉内软斑块均较治疗前减少,中间斑块和硬斑块均增多,但3组间差异均无统计学意义(P>0.05)。结论:氟伐他汀治疗冠心病能明显降低血清hs-CRP和血脂水平,A组优于B组。该药具有抗炎、稳定及逆转斑块作用,安全性好。

       

      Abstract: Objective: To investigate the effects of 40 mg and 80 mg fluvastatin on the coronary artery plaques,and levels of serum lipids and high sensitive C-reactive protein(hs-CRP) in patients with coronary heart disease,and its safety.Methods: One hundred and twenty patients with coronary heart disease were randomly divided into A group(treatment with 80 mg fluvastatin every night),B group(treatment with 40 mg fluvastatin every night) and C group(treatment with other fluvastatin and hypolipidemic drugs)(40 cases each group),and the treatment course of all cases was 6 months.The computed tomography coronary angiography in all patients was examined to calculate the coronary artery plaques before and after treatment.The serum levels of total cholesterol(TC),triglyceride(TG),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),hs-CRP and liver function in all cases were measured.Results: The differences of the serum levels of TC,TG,LDL-C,HDL-C and hs-CRP between three groups before treatment were not statistical significance(P>0.05).Compared with before treatment,the serum levels of hs-CRP,TC,TG and LDL-C in A and B groups in 6 months after treatment decreased(P<0.01),but for the level of HDL-C,it increased(P<0.01).The level of LDL-C in A group after treatment was lower than that in B group(P<0.01).After treatment,the number of fatty plaques,and the number of fibre and calcified plaques in coronary artery of A and B groups decreased and increased,respectively,the differences of whose between three groups were not statistical significance(P>0.05).Conclusions: The treatment of coronary heart disease with fluvastatin can significantly reduce the serum levels of hs-CRP and blood lipid,inhibit inflammation,and stabilize and regress the plaque of coronary artery heart.The effect of A group is better than that of B group.

       

    /

    返回文章
    返回